SoftMedx Healthcare Limited (648) has confirmed fulfillment of the resumption guidance previously imposed by the Stock Exchange, as outlined in recent announcements. Trading in the company’s shares, suspended since November 2017, is set to recommence on 3 November 2025 at 9:00 a.m. across both the original trading counter (648) and the temporary counter (2906).
The company has addressed the key guidance by publishing all outstanding financial results, demonstrating compliance with Rule 13.24 of the Listing Rules, re-establishing sufficient independent non-executive directors on its board and audit committee, and disclosing all material information. The company’s auditors rendered an unqualified opinion on its annual and interim results for 2024 and the six months ended 30 June 2025, respectively. According to the published financial data, revenue reached HK$54.6 million in 2024, with a segment profit of HK$12.3 million. In the first half of 2025, revenue was HK$35.7 million and segment profit HK$8.7 million, turning around to a net profit attributable to shareholders of HK$3.4 million.
As part of the broader restructuring effort, the company undertook a debt restructuring scheme sanctioned by the High Court of Hong Kong, helping it transition from net liabilities as of 31 December 2023 to a net asset position as of 31 December 2024. This improvement, combined with stable operations, is expected to support further investment in its principal business of distributing medical and healthcare equipment and products in Hong Kong.
Separately, the share consolidation originally approved in November 2017 remains in effect; every 20 then ordinary shares were consolidated into one consolidated share, and the board lot size changed from 2,500 old shares to 5,000 consolidated shares. Revised trading arrangements will begin on 4 November 2025, including the reopening of the original and temporary counters, the commencement of parallel trading of old and new share certificates, and a designated broker’s services for matching odd lots.
Shareholders may submit old share certificates for free exchange until 26 November 2025. After this date, a fee will be charged for each transaction. The company advises shareholders and potential investors to exercise caution when dealing in the shares. All official announcements and related updates will continue to be made in accordance with regulatory requirements.